CFRA upgrades Globe Life stock rating to Buy as SEC probe ends

Published 25/07/2025, 16:22
CFRA upgrades Globe Life stock rating to Buy as SEC probe ends

Investing.com - CFRA upgraded Globe Life (NYSE:GL) to Buy from Hold on Friday, raising its price target to $155.00 from $130.00 following the favorable resolution of an SEC investigation. The stock, currently trading at $137.40, has shown strong momentum with a P/E ratio of 10.7x and a remarkable 49% return over the past year.

The research firm cited the SEC’s decision to conclude its investigation into fraud allegations without taking any enforcement actions as a key catalyst for potential multiple expansion of Globe Life shares. According to InvestingPro analysis, Globe Life maintains a "GREAT" overall financial health score of 3.2 out of 4, with particularly strong marks in profitability and price momentum.

CFRA also raised its 2025 operating earnings per share estimate by $0.95 to $14.45 after management guided estimates higher on expected reserve releases in the third and fourth quarters amid improved mortality and underwriting claim trends.

The firm increased its 2026 operating EPS estimate by $1.00 to $15.50, noting that Globe Life’s current share price represents a valuation of 9.1 times CFRA’s 2025 EPS estimate and 8.5 times its 2026 projection.

Globe Life’s success in expanding its agent base, which rose 6% sequentially in the second quarter, was highlighted as another positive factor supporting the upgraded rating and higher price target.

In other recent news, Globe Life Inc. released its financial results for the second quarter of 2025, presenting a mixed performance. The company reported earnings per share (EPS) of $3.27, slightly exceeding the forecast of $3.25. However, Globe Life’s revenue fell short, reaching $1.48 billion compared to the anticipated $1.51 billion. Despite this revenue miss, the stock experienced a notable increase, indicating positive investor sentiment. These developments are part of the company’s ongoing financial narrative. Investors and analysts continue to monitor Globe Life’s performance closely. The company’s ability to surpass EPS expectations while facing revenue challenges draws attention to its operational dynamics.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.